UCB

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, focused on the discovery and development of innovative medicines for people living with severe diseases in immunology and neurology. With a portfolio that includes treatments for conditions like epilepsy, rheumatoid arthritis, and psoriasis, UCB operates in over 40 countries and employs around 9,000 people worldwide. The company is known for its patient-centric approach and commitment to addressing unmet medical needs.

In Spain, UCB has a significant presence with offices in Madrid and Barcelona, contributing to the company's global research and commercial activities. The Spanish operations are part of UCB's broader European network, offering opportunities for international professionals in clinical development, medical affairs, and regulatory affairs. UCB's culture emphasizes innovation, collaboration, and a strong commitment to improving patient outcomes, making it an attractive employer for those looking to work in a dynamic and purpose-driven environment.